Bemerkungen zu Haltung und Zucht des Schneckenskinks Tiliqua gerrardii (Gray, 1845) (Sauria: Scincidae)HAUSCHILD, A.Salamandra (Frankfurt am Main). 1988, Vol 24, Num 4, pp 248-257, issn 0036-3375, 10 p.Article

Use of monoclonal antibodies (UCHL1- Ki-B3) against T and B cell antigens in routine paraffin-embedded skin biopsy specimensSTERRY, W; HAUSCHILD, A.Journal of the American Academy of Dermatology. 1989, Vol 21, Num 1, pp 98-107, issn 0190-9622Article

Bestimmung der Tumormarker S-100B und MIA im Blut von Melanompatienten = Determination of tumor markers S-100B and MIA in the blood of melanoma patientsHAUSCHILD, A; EILING, S.Aktuelle Dermatologie. 2002, Vol 28, Num 8-9, pp 297-301, issn 0340-2541Article

Intraläsionäre Behandlung des klassischen Kaposi-Sarkoms mit Interferon alpha = Treatment with intralesional interferon alpha in classic Kaposi sarcomaHAUSCHILD, A; PETRES-DUNSCHE, P.Hautarzt. 1992, Vol 43, Num 12, pp 789-791, issn 0017-8470Article

Detection of Clostridium botulinum in honey by a procedure involving membrane filtration = Détection, par une méthode de filtration sur membrane, de Clostridium botulinum dans le mielHAUSCHILD, A; HILSHEIMER, R.Canadian Institute of Food Science and Technology journal. 1983, Vol 16, Num 4, pp 256-258, issn 0315-5463Article

Clostridium botulinum toxinsHAUSCHILD, A. H. W.International journal of food microbiology. 1990, Vol 10, Num 2, pp 113-124, issn 0168-1605Article

Adjuvante Therapie des Melanoms : Von unspezifischen Immunstimulanzien in die Gegenwart : Therapie maligner Hauttumoren = Adjuvant therapy of melanoma. From non-specific immune stimulants into the futureHAUSCHILD, A; KLEEBERQ, U. R.Hautarzt. 2006, Vol 57, Num 9, pp 764-772, issn 0017-8470, 9 p.Article

Hautveränderungen durch targeted therapies bei onkologischen Patienten : Kutane Nebenwirkungen zielgerichteter Therapie bei onkologischen Patienten = Skin changes as a result of targeted therapies in oncology patients ·Cutaneous side effects of targeted therapies in oncology patientsKÄHLER, K. C; HAUSCHILD, A.Der Hautarzt. 2009, Vol 60, Num 5, pp 433-439, issn 0017-8470, 7 p.Article

Loss of leucocyte common antigen (CD45) on atypical lymphocytes in the localized but not disseminated type of pagetoid reticulosisSTERRY, W; HAUSCHILD, A.British journal of dermatology (1951). 1991, Vol 125, Num 3, pp 238-242, issn 0007-0963Article

Formalinresistente Leukozyten-Differenzierungs-antigene in der Dermatohistopathologie = Formalin-resistant leucocyte differentiation antigens in dermatopathologyHAUSCHILD, A; STERRY, W.Hautarzt. 1990, Vol 41, Num 7, pp 345-352, issn 0017-8470, 8 p.Article

Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomasHAUSCHILD, A; STERRY, W.The American journal of pathology. 1989, Vol 135, Num 1, pp 177-184, issn 0002-9440, 8 p.Article

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyMALVEHY, J; HAUSCHILD, A; OLAH, J et al.British journal of dermatology (1951). 2014, Vol 171, Num 5, pp 1099-1107, issn 0007-0963, 9 p.Article

Biomarkers in melanomaGOGAS, H; EGGERMONT, A. M. M; HAUSCHILD, A et al.Annals of oncology. 2009, Vol 20, issn 0923-7534, vi8-vi13, SUP6Article

Small molecules and targeted therapies in distant metastatic diseaseHERSEY, P; BASTHOLT, L; SCHADENDORF, D et al.Annals of oncology. 2009, Vol 20, issn 0923-7534, vi35-vi40, SUP6Article

Systemische Therapie des Melanoms : Aktuelle klinische Studien : Malignes melanom = Systemic treatment of melanoma. Current clinical trialsHAUSCHILD, A; RASS, K; TILGEN, W et al.Hautarzt. 2008, Vol 59, Num 6, issn 0017-8470, 484-491 [8 p.]Article

Malignes Melanom der Uvula und des weichen Gaumens = Malignant melanoma of the uvula and soft palateWOLF, C; HAACKE, T. C; HÖFT, S et al.Hautarzt. 2005, Vol 56, Num 2, pp 156-159, issn 0017-8470, 4 p.Article

Das Lipom der Lippe: Eine seltene Differenzialdiagnose = Lipoma of the lip. A rare entityLISCHNER, S; ROSIEN, F; EILING, S et al.Hautarzt. 2002, Vol 53, Num 6, pp 400-402, issn 0017-8470Article

Sicherheitsabstände bei der Exzision des primären malignen Melanoms: Diskussionsvorschläge aufgrund von Ergebnissen aus kontrollierten klinischen Studien = Safety margins for the primary surgical excison of malignant melanoma. Proposals based on controlled clinical trialsHAUSCHILD, A; EILING, S; LISCHNER, S et al.Hautarzt. 2001, Vol 52, Num 11, pp 1003-1010, issn 0017-8470Article

Repeatable acute rhabdomyolysis with multiple organ dysfunction because of interferon α and dacarbazine treatment in metastatic melanomaHAUSCHILD, A; MÖLLER, M; LISCHNER, S et al.British journal of dermatology (1951). 2001, Vol 144, Num 1, pp 215-216, issn 0007-0963Article

Suppressed thyroid-stimulating hormone secretion in patients treated with interleukin-2 and interferon-α_2b for metastatic melanomaMÖNIG, H; HAUSCHILD, A; LANGE, S et al.The Clinical investigator. 1994, Vol 72, Num 12, pp 975-978, issn 0941-0198Article

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazineGROB, J.-J; AMONKAR, M. M; MILLER, W. H et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1428-1436, issn 0923-7534, 9 p.Article

Adjuvante systemische Therapie des Melanoms : Medikamentöse Tumortherapie in der dermatologie = Adjuvant systemic treatment of melanoma : Medical tumor therapy in dermatologyKÄHLER, K. C; EGBERTS, F; HAUSCHILD, A et al.Der Hautarzt. 2011, Vol 62, Num 6, issn 0017-8470, 414-422 [8 p.]Article

Epidemiology of invasive cutaneous melanomaMACKIE, R. M; HAUSCHILD, A; EGGERMONT, A. M. M et al.Annals of oncology. 2009, Vol 20, issn 0923-7534, vi1-vi7, SUP6Article

Surgery and radiotherapy in the treatment of cutaneous melanomaTESTORI, A; RUTKOWSKI, P; MARSDEN, J et al.Annals of oncology. 2009, Vol 20, issn 0923-7534, vi22-vi29, SUP6Article

Cutaneous malignant melanoma : ESMO Clinical Recommendations for diagnosis, treatment and follow-upDUMMER, R; HAUSCHILD, A; JOST, L et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii86-ii88, SUP2Article